²é¿´: 5395  |  »Ø¸´: 28
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

1127love

Í­³æ (³õÈëÎÄ̳)

[½»Á÷] PhD positions in LMU, Munich, Germany ÒÑÓÐ18È˲ÎÓë

Ñо¿×鼯»®ÕÐÆ¸PhDѧÉú £¨ÏêÇéÇë¼ûÏÂÃæµÄ¹ã¸æ£©£¬²©Ê¿ÆÚ¼ä¹¤×ÊÓÉDFGÏîÄ¿Ìṩ£¬ÊÕÈë°´Õյ¹úTVL-13µÈ¼¶ (50% - 65%), ˰ºó£¨Òѿ۳ý¹«Á¢Ò½ÁƱ£ÏÕ·ÑÓã©´ó¸ÅÓÐ1200 - 1500 ŷÿ¸öÔ £¨µÂ¹ú˰ºó¹¤×ʸú¸öÈ˵Ť×÷ÄêÏÞ£¬»éÒö״̬£¬ÓÐûÓÐСº¢ÓÐÖ±½Ó¹ØÏµ£©¡£µÂ¹úĽÄáºÚ´óѧע²á£¬±ÏÒµÖ®ºóÄõÄÊÇĽÄáºÚ´óѧµÄѧλ¡£

ÎÒÃÇÑо¿ËùÖ÷ÒªÊÇ´Óʶ¯ÂöÖàÑùÓ²»¯»úÀíÑо¿£¬ÒÔ¶¯ÎïÄ£ÐÍΪÖ÷¡£ÏêÇéÇë¼ûËùÀïÖ÷Ò³http://www.klinikum.uni-muenchen ... 0-People/index.html¡£ÏÖÔÚÓв»Í¬µÄÑо¿Ð¡×飬´Óʲ»Í¬·½ÏòµÄÑо¿¡£ÎÒÃÇÑо¿Ð¡×éÔÚProf. Andreas HabenichtµÄ´øÁìÏ£¬Ö÷ÒªÒÔ78ÖܵÄApoE-/-СÊóΪģÐÍ£¬Ñо¿Ñª¹ÜÍâĤµÄadaptive immune responses¡£Prof. HabenichtÔÚ2004 ¨C 2005ÄêÖ®¼ä·¢ÏÖ¶¯ÂöÖàÑùÓ²»¯Ñª¹ÜÍâĤ³öÏÖTϸ°ûºÍBϸ°û¾Û¼¯£¬Õâ¸öз¢ÏֵĽṹ±»Prof. HabenichtÃüÃûΪArtery Tertiary Lymphoid Organ£¨ATLO£©, ¾­¹ý½ü10ÄêµÄÑо¿·¢ÏÖ£¬ATLOs¿ÉÄÜ¿ØÖÆÁ˶¯ÂöÖàÑùµÄÃâÒß·´Ó¦£¬²¢¾ßÓж¯ÂöÖàÑùÓ²»¯±£»¤×÷Óã¨ÏêÇé¿É²Î¿¼ÎÄÏ×Zhao L et al., 2004, Nat Med; Moos MP et al., 2005, ATVB; Gräbner R et al., 2009, JEM; Mohanta SK and Yin C et al., 2014, Cir Res; Hu D et al., 2015, Immunity£©¡£ ¹ØÓÚProf. Andreas Habenicht£¬¿É²Î¼ûÆä·¢±íµÄÎÄÏ×http://www.ncbi.nlm.nih.gov/pubmed/?term=Habenicht+A%5BAuthor%5D¡£

¹ØÓÚÓ¢ÓïµÄÒªÇó£¬ÎÒÃDz¢²»Ç¿ÖÆÒªÇóÑÅ˼»òÕ߯äËûµÄ³É¼¨Ö¤Ã÷¡£µ«ÊDz¢²»ÊÇ˵ÎÒÃǶÔÓïÑÔûÓÐÒªÇó£¬ÎÒÃÇÆÚ´ý3¸öÔÂÖ®ºó£¬ÄãÄܹ»ÓÃÓ¢ÓïͬÆäËûµÄͬÊÂÕý³£½»Á÷£¬6¸öÔÂÖ®ºóÄܹ»ÓÃÓ¢ÓïÔÚËùÀï×öѧÊõ±¨¸æ¡£ÁíÍ⣬ÌáÐÑ´ó¼ÒÒ»¸öÏà¹ØµÄ·çÏÕÊÇ£¬¸ù¾ÝµÂ¹úµÄ·¨ÂÉ£¬Ò»°ãÒ»¿ªÊ¼¶¼ÊǸø6¸öԵŤ×÷ºÏͬ£¬¹ÍÖ÷ÊÇÓÐȨÀûÔÚ6¸öÔÂÖ®ºóÖÕÖ¹ºÏͬµÄ¡£

»¶Ó­¶Ô¿ÆÑзdz£¸ÐÐËȤµÄͬѧÇë·¢ËÍ CV + motivation letter + contact details of 2 referees µ½ Dr. Sarajo Mohanta (sarajo.mohanta@med.uni-muenchen.de) or Dr. Changjun Yin (changjun.yin@med.uni-muenchen.de). £¨Ö®Ç°ÓÐЩͬѧ»¹È±ÁËÄÄЩÎļþ¸Ï½ô²¹·¢Ò»Ï°ɣ¡£©

ÆäÖÐÒ»¸öְλÖ÷Òª´ÓÊÂnext-generation sequencing·½ÃæµÄ¹¤×÷£¬Ìرð»¶Ó­ÓÐNGSÎÄ¿âÖÆ±¸£¬Êý¾Ý·ÖÎöµÈ¹¤×÷¾­ÑéµÄͬѧ¡£
ÁíÍâÒ»¸öְλÖ÷Òª´Óʶ¯ÂöÖàÑùÓ²»¯ºÍÉñ¾­ÏµÍ³crosstalk¡£
һЩ¾ßÌåµÄÒªÇóÇë×¢Òâ¿´ÏÂÃæµÄÓ¢ÎÄ¹ã¸æ¡£

PhD positions for projects in basic cardiovascular research funded by the German Research Council.

We are recruiting PhD candidates at the Institute for Cardiovascular Prevention (IPEK) in Munich (http://www.klinikum.uni-muenchen ... search/index.html). PhD students will work in an international team of experienced staff, PhD students, and postdocs. Salary according to TV-L (duration 3 years). Interview expenses will not be reimbursed.
Research areas:
Cardiovascular research in atherosclerosis T/B cell autoimmunity and atherosclerosis-nervous system crosstalk in aged hyperlipidemic mice.
Techniques:
Flow cytometry, confocal laser scanning microscopy, next-generation sequencing, software application, mouse dissection, microsurgery, and cell culture.
Requirements:
Immunology, cell biology, molecular biology and microscopy. Interest in cardiovascular diseases, fluent English, teamwork, commitment, resilience, and desire to learn new techniques.
Contact:
Please send your application, including CV, motivation letter, and contact details of 2 referees to Dr. Sarajo Mohanta (sarajo.mohanta@med.uni-muenchen.de) or Dr. Changjun Yin (changjun.yin@med.uni-muenchen.de).
Suggested Readings:
1. Gräbner et al. 2009. Journal of Experimental Medicine 206, 233-248.
2. Hu and Mohanta et al. 2015. Immunity 42, 1100-1115.
Address:
Andreas Habenicht, M.D.; Professor of Medicine; Institute for Cardiovascular Disease Prevention (IPEK); Ludwig-Maximilians-University (LMU) Munich Pettenkoferstr. 9; 80336 Munich, Germany

±¾ÕÐÆ¸ÐÅÏ¢À´Ô´£ºhttp://www.klinikum.uni-muenchen ... toranden/index.html

[ Last edited by 1127love on 2016-3-22 at 21:56 ]
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÉúÎ﹤³Ìʦ

ľ³æ (ÕýʽдÊÖ)

Ëͺ컨һ¶ä
лл·ÖÏí£¬CVÒÑ·¢
13Â¥2016-03-22 23:47:17
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 29 ¸ö»Ø´ð

wavehy

½ð³æ (ÕýʽдÊÖ)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
ûдÐèÒªÄÄЩרҵµÄѧÉúÂð£¿
2Â¥2016-03-21 19:59:43
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

1127love

Í­³æ (³õÈëÎÄ̳)

ÒýÓûØÌû:
2Â¥: Originally posted by wavehy at 2016-03-21 19:59:43
ûдÐèÒªÄÄЩרҵµÄѧÉúÂð£¿

ÉúÎï»òÕßҽѧÏà¹ØµÄ¶¼¿ÉÒԵġ£
3Â¥2016-03-21 20:27:45
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

shenbaihua

ľ³æ (ÕýʽдÊÖ)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
Äܱ¾¿ÆÖ±ÉêÂð£¿ÓйýÒ»ÄêÔÚÃÀ¹ú¿ÆÑÐʵϰµÄ¾­Àú

·¢×ÔСľ³æIOS¿Í»§¶Ë
4Â¥2016-03-21 21:06:17
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 085600 ²ÄÁÏÓ뻯¹¤ 329·ÖÇóµ÷¼Á +9 Mr. Z 2026-03-25 9/450 2026-03-26 10:36 by baoball
[¿¼ÑÐ] »·¾³×¨Ë¶324·ÖÇóµ÷¼ÁÍÆ¼ö +3 ÐùСÄþ¡ª¡ª 2026-03-26 3/150 2026-03-26 10:17 by JourneyLucky
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤304ÇóBÇøµ÷¼Á +3 Çñgl 2026-03-26 3/150 2026-03-26 09:42 by ÍõЦÓîÒ»¶¨ÊÇÑо
[¿¼ÑÐ] ´ò¹ýºÜ¶à¾ºÈü£¬085406¿ØÖƹ¤³Ì300·Ö£¬Çóµ÷¼Á +3 askeladz 2026-03-26 3/150 2026-03-26 09:08 by ¸øÄãÄã×¢ÒâÐÝÏ¢
[¿¼ÑÐ] Çóµ÷¼Á +3 «lty 2026-03-25 4/200 2026-03-25 23:25 by «lty
[¿¼ÑÐ] 08¹¤Ñ§µ÷¼Á +13 Óû§573181 2026-03-20 18/900 2026-03-25 22:00 by zbssa
[¿¼ÑÐ] 334·Ö Ò»Ö¾Ô¸ÎäÀí-080500 ²ÄÁÏÇóµ÷¼Á +4 ÀîÀî²»·þÊä 2026-03-25 4/200 2026-03-25 21:26 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] Ò»Ö¾Ô¸ÖÐÄÏ´óѧ»¯Ñ§Ñ§Ë¶0703×Ü·Ö337Çóµ÷¼Á +7 niko- 2026-03-22 7/350 2026-03-25 20:14 by qingfeng258
[¿¼ÑÐ] 333Çóµ÷¼Á +6 87639 2026-03-21 11/550 2026-03-25 16:17 by 87639
[¿¼ÑÐ] 278Çóµ÷¼Á +4 ÎÒ¿ÉÒÔÉϰ¶µÄ¶Ô 2026-03-19 4/200 2026-03-25 11:01 by userper
[¿¼ÑÐ] ʳƷר˶ һ־Ը˫һÁ÷ 328 +3 xiaom99 2026-03-21 4/200 2026-03-24 21:20 by lailaisimei
[¿¼ÑÐ] 305·ÖÇóµ÷¼Á£¨Ê³Æ·¹¤³Ì£© +5 Sxy112 2026-03-21 7/350 2026-03-24 12:27 by 544594351
[¿¼ÑÐ] 335Çóµ÷¼Á +4 yuyuÓî 2026-03-23 5/250 2026-03-23 23:49 by Txy@872106
[¿¼ÑÐ] 284Çóµ÷¼Á +3 yanzhixue111 2026-03-23 6/300 2026-03-23 22:58 by pswait
[ÂÛÎÄͶ¸å] ¼±·¢ºËÐÄÆÚ¿¯ÂÛÎÄ +3 ÏÍ´ïÎʽò 2026-03-23 5/250 2026-03-23 17:13 by ÃÃ×Ó²»ºÃÈÇ
[¿¼ÑÐ] Ò»Ö¾Ô¸»ªÖпƼ¼´óѧ071000£¬Çóµ÷¼Á +4 ÑØ°¶Óб´¿Ç6 2026-03-21 4/200 2026-03-22 07:21 by ilovexiaobin
[¿¼ÑÐ] Ò»Ö¾Ô¸ÖØÇì´óѧ085700×ÊÔ´Óë»·¾³×Ü·Ö308Çóµ÷¼Á +7 īīĮ 2026-03-20 7/350 2026-03-21 16:36 by barlinike
[¿¼ÑÐ] 279Çóµ÷¼Á +5 ºìÒÂÒþ¹Ù 2026-03-21 5/250 2026-03-21 14:59 by lature00
[¿¼ÑÐ] 332Çóµ÷¼Á +3 ·ï»ËÔº¶¡Õæ 2026-03-20 3/150 2026-03-21 10:27 by luoyongfeng
[¿¼ÑÐ] Ò»Ö¾Ô¸ÄÏÀí¹¤085701»·¾³302Çóµ÷¼ÁԺУ +3 ¿ûè÷ÎÀ¶Ó 2026-03-20 3/150 2026-03-20 19:28 by zhukairuo
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û